CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 22 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,876 | -32.7% | 207,025 | +0.0% | 0.00% | – |
| Q3 2022 | $34,000 | -34.6% | 207,024 | 0.0% | 0.00% | – |
| Q2 2022 | $52,000 | -52.7% | 207,024 | 0.0% | 0.00% | – |
| Q1 2022 | $110,000 | -13.4% | 207,024 | 0.0% | 0.00% | – |
| Q4 2021 | $127,000 | -46.9% | 207,024 | -11.5% | 0.00% | – |
| Q3 2021 | $239,000 | -45.2% | 234,043 | -1.7% | 0.00% | -100.0% |
| Q2 2021 | $436,000 | -20.7% | 238,024 | -54.7% | 0.00% | 0.0% |
| Q1 2021 | $550,000 | +62.2% | 525,224 | +19.6% | 0.00% | 0.0% |
| Q4 2020 | $339,000 | -23.3% | 439,024 | +67.6% | 0.00% | 0.0% |
| Q3 2020 | $442,000 | -75.3% | 262,024 | +22.8% | 0.00% | -80.0% |
| Q2 2020 | $1,790,000 | +60.3% | 213,324 | +0.1% | 0.01% | +25.0% |
| Q1 2020 | $1,117,000 | +1.0% | 213,117 | +5.2% | 0.00% | +33.3% |
| Q4 2019 | $1,106,000 | +14.1% | 202,511 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $969,000 | -29.8% | 198,987 | -0.1% | 0.00% | -40.0% |
| Q2 2019 | $1,380,000 | -16.5% | 199,098 | -16.3% | 0.01% | -16.7% |
| Q1 2019 | $1,653,000 | +41.9% | 237,834 | +19.2% | 0.01% | +20.0% |
| Q4 2018 | $1,165,000 | -23.6% | 199,571 | -1.1% | 0.01% | -16.7% |
| Q3 2018 | $1,524,000 | +51.0% | 201,853 | +1.0% | 0.01% | +50.0% |
| Q2 2018 | $1,009,000 | -16.7% | 199,821 | +0.6% | 0.00% | -20.0% |
| Q1 2018 | $1,212,000 | -4.6% | 198,635 | +10.9% | 0.01% | 0.0% |
| Q4 2017 | $1,271,000 | +2.1% | 179,050 | +2.8% | 0.01% | -16.7% |
| Q3 2017 | $1,245,000 | +13.9% | 174,172 | +0.4% | 0.01% | 0.0% |
| Q2 2017 | $1,093,000 | -20.6% | 173,475 | +3.9% | 0.01% | -25.0% |
| Q1 2017 | $1,377,000 | 0.0% | 166,950 | +2.4% | 0.01% | 0.0% |
| Q4 2016 | $1,377,000 | +23.9% | 162,967 | -0.4% | 0.01% | +14.3% |
| Q3 2016 | $1,111,000 | +201.1% | 163,567 | +32.4% | 0.01% | +133.3% |
| Q2 2016 | $369,000 | +6050.0% | 123,567 | +3886.0% | 0.00% | – |
| Q1 2016 | $6,000 | +100.0% | 3,100 | +47.6% | 0.00% | – |
| Q4 2015 | $3,000 | 0.0% | 2,100 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |